Atria Investments’s Utah Medical Products UTMD Stock Holding History

Atria Investments’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$487K	Buy	7,054 +2,122	+43%	+$141K	﹤0.01%	1546
2026 Q1	$306K	Buy	4,932 +7	+0.1%	+$441	﹤0.01%	1744
2025 Q4	$276K	Sell	4,925 -162	-3%	-$9.39K	﹤0.01%	1783
2025 Q3	$320K	Sell	5,087 -1,316	-21%	-$77.8K	﹤0.01%	1684
2025 Q2	$364K	Sell	6,403 -3,550	-36%	-$193K	﹤0.01%	1595
2025 Q1	$558K	Buy	9,953 +1,054	+12%	+$63.1K	0.01%	1293
2024 Q4	$547K	Buy	8,899 +1,712	+24%	+$111K	0.01%	1281
2024 Q3	$481K	Sell	7,187 -62	-0.9%	-$4.21K	0.01%	1339
2024 Q2	$484K	Buy	+7,249	New	+$493K	0.01%	1320

Other funds holding UTMD

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atria Investments's UTMD Position: Q2 2026 in Review

Atria Investments increased its Utah Medical Products (UTMD) stake by 43% in Q2 2026, buying an estimated $141K and bringing the position to 7,054 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Atria Investments first reported a position in UTMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $558K in Q1 2025. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

Atria Investments held 7,054 shares of Utah Medical Products worth $487K as of Q2 2026.
Atria Investments bought 2,122 Utah Medical Products shares in Q2 2026, an estimated $141K.
Utah Medical Products made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1546 holding.
Atria Investments first reported a position in Utah Medical Products in Q2 2024 and has held it in 9 quarters since.
Atria Investments's Utah Medical Products position peaked at $558K in Q1 2025.
114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.